Hysolv Animal Health has been appointed exclusive distributors for the market-leading swine flu vaccine, Respiporc Flu 3, in the United Kingdom and Republic of Ireland.
The two-dose, inactivated vaccine provides a high level of immunity in pigs for up to six months, depending on their age. If administered to a sow 14 days before farrowing, it will provide passive maternal immunity to her piglets for 33 days.
“In the UK, outbreaks of swine flu tend to be sporadic but when the disease occurs it can have a serious financial impact on the pig herd,” said Hysolv director Richard Brealey. “There can be morbidity and deaths in sows, aborted litters and, when spread to finishing stock, the disease affects production performance.”
Respiporc Flu 3 was developed in Germany by IDT Biologika. It is a POM-V (prescription-only medicine) only available through veterinary surgeons. Previously distributed by Merial Animal Health Ltd as Gripovac 3, it has an excellent safety record and is the only vaccine effective against three strains of swine flu.
Swine flu tends to circulate in pig populations, which can act as a ‘mixing pot’ for the viruses with the potential for jumping to other species, including humans.
www.hysolv.co.uk
